Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing, 3rd Edit...( NEW YORK Sept. 22 /- Repo...),Health

NEW YORK, Sept. 22 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing, 3rd Edition

http://www.reportlinker.com/p099450/Pharmaceutical-Outsourcing-Opportunities-Post-Launch-Contract-Manufacturing-and-Contract-Sales-and-Marketing-3rd-Edition.html

This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector.

A major factor driving the upward trend in the number of manufacturing projects being outsourced is that specialized production, i.e., sterile manufacturing, biopharmaceutical manufacturing and specialized processes, such as chiral chemistry and improvements in catalyst activity, is often not included in the core competency of pharmaceutical and biotechnology drug makers.

Detail on Biopharmaceutical Markets

The growing number of biotechnology-driven protein and peptide drugs, antibiotics, chemotherapeutic agents and other compounds administered as sterile injectables, with its concomitant technological requirements, has brought about an increase in the demand for contract sterile manufacturing services. The sheer numbers of biologics in the pipeline are driving drug makers to outsource specialized production rather than build new plants.

As part of its unique coverage of the outsourcing m
'/>"/>